Director/PDMR Shareholding - Grant of options

Summary by AI BETAClose X

Gelion PLC announced the grant of 270,400 share options to Chief Executive Officer John Wood at an exercise price of 0.1 pence, bringing his total holdings to 2,974,400 options. These options vest fully on June 30, 2026, and expire on March 2, 2036, with provisions for malus, clawback, and vesting upon corporate events. Following this grant, the company has approximately 17.34 million options outstanding, representing 7.6% of its issued share capital.

Disclaimer*

Gelion PLC
03 March 2026
 

3 March 2026

Gelion PLC

(the "Company" or the "Group")

Director/PDMR Shareholding - Grant of options 

Gelion plc (AIM: GELN), the global energy storage innovator, announces the grant of options ("Options") to subscribe for new ordinary shares ("Ordinary Shares") to John Wood, Chief Executive Officer, in accordance with the terms of the Group's Share Option Plan.

 

Mr Wood has been granted 270,400 Options on 3 March 2026. These Options have an exercise price of 0.1 pence and are subject to vesting and exercise conditions of the Share Option Plan as set out below. Following this grant the total number of Options held by Mr Wood is 2,974,400.

Subsequent to this issue of Options, the Group has approximately 17.34 million Options in issue, representing 7.6% of the Company's issued share capital.

Summary of terms of these Options

These Options will vest in full on 30 June 2026 provided that Mr Wood is in continuous employment with Gelion. The Options expire, to the extent that they have not been exercised, on 2 March 2036.

All Options are subject to both malus and clawback provisions and good and bad leaver provisions. All unvested options will vest in certain corporate events such as a takeover of the company or a change of control. In these circumstances the Options would normally vest and become exercisable in full unless the Board decides that the Option will be pro-rated to take account of the date the corporate event took place during the normal vesting period.

 

Enquiries:

Gelion plc
John Wood, CEO
Amit Gupta, CFO                                                                                                   

via Tavistock

 

Strand Hanson Limited (Nominated and Financial Adviser)
Christopher Raggett / Rob Patrick / Harry Marshall

 

+44 (0) 20 7409 3494

Oberon Capital (Joint Broker)
Nick Lovering / Mike Seabrook / Adam Pollock

 

+44 (0) 20 3179 5300

Allenby Capital Limited (Joint Broker)

Jos Pinnington / Lauren Wright (Sales and Corporate Broking)

Alex Brearley / Ashur Joseph (Corporate Finance)

 

+44 (0) 20 3328 5656

Tavistock (Financial & Corporate PR)
Simon Hudson / Nick Elwes / Saskia Sizen

+44 (0) 20 7920 3150
gelion@tavistock.co.uk

 

 

 

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

John Wood

2. 

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Gelion plc

b)

LEI:

2138008NC7YL3MCUDR84

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1p each ("Ordinary Shares")             

GB00BNBQZD59

b)

Nature of the transaction:

Grant of options 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.1p

270,400


d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 (c) above 

e)

Date of the transaction:

3 March 2026

f)

Place of the transaction:

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Gelion (GELN)
UK 100

Latest directors dealings